Benazepril hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for benazepril hydrochloride and what is the scope of patent protection?
Benazepril hydrochloride
is the generic ingredient in four branded drugs marketed by Amneal Pharms, Ani Pharms, Aurobindo Pharma, Chartwell Rx, Corepharma, Genpharm, Heritage Pharma, Prinston Inc, Rising, Sun Pharm Inds Ltd, Teva, Zydus Lifesciences, Validus Pharms, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, and Sandoz, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for benazepril hydrochloride. Twenty-seven suppliers are listed for this compound.
Summary for benazepril hydrochloride
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 17 |
NDAs: | 21 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 27 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Clinical Trials: | 44 |
Patent Applications: | 3,102 |
What excipients (inactive ingredients) are in benazepril hydrochloride? | benazepril hydrochloride excipients list |
DailyMed Link: | benazepril hydrochloride at DailyMed |
Recent Clinical Trials for benazepril hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Northwell Health | Phase 2 |
Lupus Research Alliance | Phase 2 |
Shanghai Children's Hospital | Phase 2 |
Pharmacology for benazepril hydrochloride
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure |
Anatomical Therapeutic Chemical (ATC) Classes for benazepril hydrochloride
US Patents and Regulatory Information for benazepril hydrochloride
Expired US Patents for benazepril hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-001 | Jun 25, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-004 | Jun 25, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-003 | Jun 25, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-002 | Jun 25, 1991 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Benazepril hydrochloride Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.